Calcium-mediated cellular signals: A story of failures

Trends in Biochemical Sciences

Volumn 29, Issue 7, 2004, Pages 371-379

  Carafoli, Ernesto ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE;

ACUTE PANCREATITIS; ALZHEIMER DISEASE; CALCIUM SIGNALING; CELL TYPE; DARIER DISEASE; EATON LAMBERT SYNDROME; FAMILIAL AMYLOID POLYNEUROPATHY; GENE MUTATION; HAILEY HAILEY DISEASE; HUMAN; HUNTINGTON CHOREA; KIDNEY POLYCYSTIC DISEASE; LIMB GIRDLE MUSCULAR DYSTROPHY; MALIGNANT HYPERTHERMIA; MISSENSE MUTATION; MUCOLIPIDOSIS; MUSCLE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RETINA DISEASE; REVIEW;

ANIMALS; CALCIUM; CALCIUM CHANNELS; CALCIUM SIGNALING; CALCIUM-BINDING PROTEINS; CELL PHYSIOLOGY; HUMANS; MITOCHONDRIA;

EID: 3242761518     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2004.05.006     Document Type: Review

References (79)

1. Carafoli E., et al. Generation, control, and processing of cellular calcium signals. Crit. Rev. Biochem. Mol. Biol. 36:2001;107-260
2. 2+ homeostasis and disease. Cell Calcium. 28:2000;1-21
3. Rizzuto R., Pozzan T. When calcium goes wrong: genetic alterations of a ubiquitous signaling route. Nat. Genet. 34:2003;135-141
4. +) switch aligns the active site of calpain. Cell. 108:2002;649-660
5. Richard I., et al. Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell. 81:1995;27-40
6. Horikawa Y., et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat. Genet. 26:2000;163-175
7. Baier L.J., et al. A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J. Clin. Invest. 106:2000;R69-R73
8. Maury C.P.J., et al. Finnish hereditary amyloidosis. Aminoacid sequence homology between the amyloid fibril protein and human plasma gelsolin. FEBS Lett. 260:1990;85-87
9. Paunio T., et al. Cells of the neuronal lineage play a major role in the generation of amyloid precursor fragments in gelsolin-related amyloidosis. J. Biol. Chem. 273:1998;16319-16324
10. +) affinity determines susceptibility to furin proteolysis and familial amyloidosis of Finnish type. J. Mol. Biol. 334:2003;119-127
11. Rand J.H., et al. Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of woman and antiphospholipid antibodies and recurrent spontaneous abortion. Am. J. Obstet. Gynecol. 171:1994;1566-1572
12. Hajjar K.A., Krishnan S. Annexin II: a mediator of the plasmin/plasminogen activator system. Trends Cardiovasc. Med. 9:1999;128-138
13. Menell J.S., et al. Annexin II and bleeding in acute promyelocytic leukemia. N. Engl. J. Med. 340:1999;1035-1036
14. Kim J., Hajjar K.A. AnnexinII: a plasminogen-plasminogen activator co-receptor. Front. Biosci. 7:2002;d341-d348
15. Gunteski-Hamblin A.M., et al. Annexin VI overexpression targeted to heart alters cardiomyocyte function in transgenic mice. Am. J. Physiol. 270:1996;H1091-H1100
16. 2+-binding proteins. Biochem. J. 353:2001;1-12
17. Sokal I., et al. GCAP1 (Y99C) mutant is constitutively active in autosomal dominant cone dystrophy. Mol. Cell. 2:1998;129-133
18. 2+ binding proteins in the retina: from discovery to etiology of human disease. Biochim. Biophys. Acta. 1498:2000;233-251
19. Polans A.S., et al. Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy. Proc. Natl. Acad. Sci. U. S. A. 92:1995;9176-9180
20. Leissring M.A., et al. Calsenilin reverses presenilin-mediated enhancement of calcium signaling. Proc. Natl. Acad. Sci. U. S. A. 97:2000;8590-8593
21. Heizmann C.W., et al. S100 Proteins: structure, functions and pathology. Front. Biosci. 7:2002;1356-1368
22. Van Ginkel P.R., et al. The identification and differential expression of calcium binding proteins associated with ocular melanoma. Biochim. Biophys. Acta. 1448:1998;290-297
23. Brody I.A. Muscle contracture induced by exercise. A syndrome attributable to decreased relaxing factor. N. Engl. J. Med. 281:1969;187-192
24. 2+ pump, cause Darier disease. Nat. Genet. 21:1999;271-277
25. 2+ pump. J. Biol. Chem. 276:2001;26737-26740
26. 2+-ATPases 2B involvement in human prostate cancer cell growth control. J. Biol. Chem. 276:2001;47608-47614
27. Gélébart P., et al. Expression of endomembrane calcium pumps in colon and gastric cancer cells. J. Biol. Chem. 277:2002;26310-26320
28. MacLennan D.H., Kranias E.G. Phospholamban: a crucial regulator of cardiac contractility. Nat. Rev. Mol. Cell Biol. 4:2003;566-577
29. 2+-ATPase gene cause deafness in deafwaddler mice. Nat. Genet. 19:1998;390-394
30. 2+-ATPase gene causes deafness in Wriggle Mouse Sagami. Biochem. Biophys. Res. Commun. 261:1999;773-778
31. 2+-ATPase isoform 2. J. Biol. Chem. 273:1998;18693-18696
32. Penheiter A.R., et al. Characterization of the deafwaddler mutant of the rat plasma membrane calcium-ATPase 2. Hear. Res. 162:2001;19-28
33. Sudbrak R., et al. Hailey-Hailey disease is caused by mutations in ATP2C1 encoding a novel Ca(2+) pump. Hum. Mol. Genet. 9:2000;1131-1140
34. Hu Z., et al. Mutations in ATP2C1, encoding a calcium pump, cause Hailey-Hailey disease. Nat. Genet. 24:2000;61-65
35. Ertel A.E., et al. Nomenclature of voltage-gated calcium channels. Neuron. 25:2000;533-535
36. Jurkat-Rott K., et al. A calcium channel mutation causing hypokalemic periodic paralysis. Hum. Mol. Genet. 3:1994;1415-1419
37. Monnier N., et al. Malignant-hyperthermia susceptibility is associated with a mutation of the α1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle. Am. J. Hum. Genet. 60:1997;1316-1325
38. Bech-Hansen N.T., et al. Loss of function mutations in a calcium-channel α1-subunit gene in Xp11.23 cause incomplete X-linked congenital stationary night blindness. Nat. Genet. 19:1998;264-267
39. Chaudhari N. A single nucleotide deletion in the skeletal muscle-specific calcium channel transcript of muscular dysgenesis (mdg) mice. J. Biol. Chem. 267:1992;25636-25639
40. 2+ channel gene CACNL1A4. Cell. 87:1996;543-552
41. Yeu Q., et al. De novo mutation in CACNA1A caused acetazolamide- responsive episodic ataxia. Am. J. Med. Genet. 77:1998;298-301
42. Zhuchenko O., et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α1A-voltage- dependent calcium channel. Nat. Genet. 15:1997;62-69
43. v3.2 T-type calcium channel associated with childhood absence epilepsy. J. Biol. Chem. 279:2004;9681-9684
44. Escayg A., et al. Coding and noncoding variation of the human calcium-channel β4-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia. Am. J. Hum. Genet. 66:2000;1531-1539
45. 2+ channel β subunit gene Cchb4 is associated with ataxia and seizures in the lethargic (Ih) mouse. Cell. 88:1997;385-392
46. Kim Y.I., Neher E. IgG from patients with Lambert-Eaton syndrome blocks voltage-dependent calcium channels. Science. 239:1988;405-408
47. 2+ flux in a human small cell carcinoma line. Nature. 317:1985;737-739
48. MacLennan D.H., Phillips M.S. Malignant hyperthermia. Science. 256:1992;789-794
49. Quane K.A., et al. Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia. Nat. Genet. 5:1993;51-55
50. Takeshima H., et al. Excitation-contraction uncoupling and muscular degeneration in mice lacking functional skeletal muscle ryanodine-receptor gene. Nature. 369:1994;556-559
51. Wehrens X.H., et al. FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. Cell. 113:2003;829-840
52. Tiso N., et al. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum. Mol. Genet. 10:2001;189-194
53. Street V.A., et al. The type 1 inositol 1,4,5-trisphosphate receptor gene is altered in the opisthotonos mouse. J. Neurosci. 17:1997;635-645
54. Tang T.S., et al. Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1. Neuron. 39:2003;227-239
55. Panov A.V., et al. Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nat. Neurosci. 5:2002;731-736
56. Goffredo D., et al. Calcium-dependent cleavage of endogenous wild-type Huntingtin in primary cortical neurons. J. Biol. Chem. 277:2002;39594-39598
57. Gonzalez-Perret S., et al. Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca2+-permeable nonselective cation channel. Proc. Natl. Acad. Sci. U. S. A. 98:2001;1182-1187
58. LaPlante J.M., et al. Identification and characterization of the single channel function of human mucolipin-1 implicated in mucolipidosis type IV, a disorder affecting the lysosomal pathway. FEBS Lett. 532:2002;183-187
59. Sutton R., et al. Signal transduction, calcium, and acute pancreatitis. Pancreatol. 3:2003;497-505
60. 2+-selective cation channel TRPV6 in human prostate cancer: a novel prognostic marker for tumor progression. Oncogene. 22:2003;7858-7861
61. v channels. Modulator. 16:2002;4-8
62. Kretsinger R.H., Nockholds C.E. Carp muscle calcium binding protein.II structure determination and general description. J. Biol. Chem. 248:1973;3313-3326
63. MacLennan D.H. Purification and properties of an adenosine triphosphatase from sarcoplasmic reticulum. J. Biol. Chem. 245:1970;4508-4518
64. Toyoshima C., et al. Crystal structure of the calcium pump of sarcoplasmic reticulum at 2.6 Å resolution. Nature. 405:2000;647-655
65. Toyoshima C., Nomura H. Structural changes in the calcium pump accompanying the dissociation of calcium. Nature. 418:2002;605-611
66. 2+ from a nonmitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate. Nature. 306:1983;67-69
67. Takeshima H., et al. Primary structure and expression from complementary DNA of skeletal muscle ryanodine receptor. Nature. 339:1989;439-445
68. + into a calcium-mobilizing metabolite. Cell Regul. 2:1991;203-209
69. 2+ store, with functional properties distinct from those of the endoplasmic reticulum. EMBO J. 17:1998;5298-5308
70. Santella L., Carafoli E. Calcium signaling in the cell nucleus. FASEB J. 11:1997;1091-1109
71. Aarhus R., et al. ADP-ribosyl cyclase and CD38 catalyze the synthesis of a calcium-mobilizing metabolite from NADP. J. Biol. Chem. 270:1995;30327-30333
72. 2+ release mechanism gated by the novel pyridine nucleotide, NAADP. Trends Pharmacol. Sci. 18:1997;108-110
73. 2+ current that is dependent on F-actin cytoskeleton. FASEB J. 17:2003;1907-1909
74. Carafoli E. Mitochondria and calcium: ups and downs of an unusual relationship. Trends Biochem. Sci. 28:2003;175-181
75. Kirichok Y., et al. The mitochondrial calcium uniporter is a highly selective ion channel. Nature. 427:2004;360-364
76. Carafoli E., et al. The release of calcium from heart mitochondria by sodium. J. Mol. Cell. Cardiol. 6:1974;361-371
77. Carafoli E. The calcium cycle of mitochondria. FEBS Lett. 104:1979;1-5
78. 2+-sensitive dehydrogenases within intact uncoupled mitochondria from the white and brown adipose tissue of the rat. Biochem. J. 190:1980;95-105
79. 3-sensitive channels that are sensed by neighbouring mitochondria. Science. 262:1993;744-747